Back to Journals » International Journal of Nanomedicine » Volume 11

A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer

Total article views   Abstract views HTML views PDF downloads Totals
7,820 Dovepress* 3,930 2,978+ 1,077 6,908
PubMed Central* 0 912 277 912
Totals 3,930 3,890 1,354 7,820
*Since 8 January 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 4 4

View citations on PubMed Central and Google Scholar